Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 130, 54-61
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01AG034924, RF1AG053000, R35NS097283, P50AG047270)
- Falk Medical Research Trust
This publication has 47 references indexed in Scilit:
- Prion Protein-mediated Toxicity of Amyloid-β Oligomers Requires Lipid Rafts and the Transmembrane LRP1Journal of Biological Chemistry, 2013
- RETRACTED: The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's DiseaseJournal of Neuroscience, 2012
- Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neuronsNature Neuroscience, 2012
- Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion ProteinThe Journal of Neuroscience, 2010
- Expression of complement system components during aging and amyloid deposition in APP transgenic miceJournal of Neuroinflammation, 2009
- Multimodal techniques for diagnosis and prognosis of Alzheimer's diseaseNature, 2009
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomersNature, 2009
- Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's‐disease‐model transgenic mice shown as by micromagnetic resonance imagingJournal of Neuroscience Research, 2008
- Effects of Memantine on Neuronal Structure and Conditioned Fear in the Tg2576 Mouse Model of Alzheimer's DiseaseNeuropsychopharmacology, 2008
- The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies)2007